臨床試驗用品市場規模、佔有率、成長分析（按階段、按產品和服務、按最終用途、按治療方法、按地區）－產業預測 2025-2032

臨床試驗用品市場規模預計在 2023 年達到 31 億美元，並將從 2024 年的 33.1 億美元成長到 2032 年的 56.5 億美元，預測期內（2025-2032 年）的複合年成長率為 6.9%。

受生物製藥和醫藥領域研發成本上升、臨床試驗增加、新興國家藥物開發成本飆漲等因素影響，全球臨床試驗用品市場大幅成長。然而，由於藥物研究高成本以及新冠疫情的持續影響，這種成長面臨挑戰。全球慢性病的流行進一步推動了該領域的需求。此外，契約製造製造商和服務供應商在提供外包解決方案方面至關重要，使製藥公司能夠改進藥物配方並加強與同行的合作。已建立的物流和分銷夥伴關係，例如 Fisher Clinical Services 和 Parexel International，也在推動市場發展，將臨床試驗用品定位為現代藥物開發的基石。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析

臨床試驗用品市場規模（依階段分類）及複合年成長率（2025-2032）

• 市場概覽
• 第一階段
• 第二階段
• 第三階段
• 其他

臨床試驗用品市場規模（依產品及服務）及複合年成長率（2025-2032）

• 市場概覽
• 製造業
• 儲存和運輸
• 供應鏈管理

臨床試驗用品市場規模（依最終用途和複合年成長率） (2025-2032)

• 市場概覽
• 製藥
• 生物製藥
• 醫療設備
• 其他

臨床試驗用品市場規模（依治療方法分類）及複合年成長率（2025-2032）

• 市場概覽
• 腫瘤學
• 中樞神經系統
• 心血管系統
• 感染疾病
• 代謝紊亂
• 其他

臨床試驗用品市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Almac Group（UK）
• Thermo Fisher Scientific Inc.（USA）
• Marken（UPS）（USA）
• PCI Pharma Services（USA）
• Sharp Services LLC（USA）
• Cencora, Inc.（USA）
• Myonex（USA）
• Clinigen Limited（UK）
• Inceptua Group（Luxembourg）
• Eurofins Scientific（Luxembourg）
• IQVIA（USA）
• Parexel International Corporation（USA）
• ICON plc（Ireland）
• Catalent, Inc.（USA）
• Piramal Pharma Solutions（India）
• Biocair（UK）
• Lonza（Switzerland）
• World Courier（USA）
• Klifo A/S（Denmark）
• DHL Supply Chain（Germany）

結論和建議

Clinical Trial Supplies Market size was valued at USD 3.1 billion in 2023 and is poised to grow from USD 3.31 billion in 2024 to USD 5.65 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The global clinical trial supplies market is witnessing significant growth driven by rising R&D expenditures within biopharmaceutical and pharmaceutical sectors, an increase in clinical trials, and escalating drug development costs in developed nations. However, this growth faces challenges due to the high costs associated with drug research and the lingering effects of the COVID-19 pandemic. The increasing prevalence of chronic illnesses worldwide further fuels demand in this sector. Moreover, contract manufacturers and service providers are crucial in offering outsourcing solutions, allowing pharmaceutical companies to refine drug formulations and enhance collaboration with peers. Established logistics and distribution partnerships, such as with Fisher Clinical Services and PAREXEL International, are also boosting market expansion, positioning clinical trial supplies as a cornerstone of modern drug development.

Top-down and bottom-up approaches were used to estimate and validate the size of the Clinical Trial Supplies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Clinical Trial Supplies Market Segments Analysis

Global Clinical Trial Supplies Market is segmented by Phase, Products and Services, End Use, Therapeutic and region. Based on Phase, the market is segmented into Phase I, Phase II, Phase III and Others. Based on Products and Services, the market is segmented into Manufacturing, Storage and Distribution and Supply Chain Management. Based on End Use, the market is segmented into Pharmaceutical, Biologics, Medical device and Others. Based on Therapeutic, the market is segmented intooncology, CNS, Cardiovascular, Infectious disease, Metabolic disorders and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Clinical Trial Supplies Market

A significant driver of the global clinical trial supplies market is the growing emphasis on precision medicine. As therapies become more tailored to individual patients, there is an escalating demand for innovative treatment solutions and biologic medications. This shift necessitates the development of specialized clinical trial supplies to effectively manage the complexities associated with advanced clinical trial designs and the stratification of patients. Consequently, the evolution of precision medicine is propelling the need for refined and targeted clinical trial resources, ultimately shaping the landscape of clinical trials to better meet the diverse needs of patients and researchers alike.

Restraints in the Clinical Trial Supplies Market

The global clinical trial supplies market faces significant challenges due to disruptions in the global supply chain. Factors such as political conflicts, natural disasters, and health crises can severely impact the availability of essential materials and transportation logistics. These disruptions can lead to delays in the initiation of clinical trials and result in increased operational expenses, ultimately diminishing the overall efficiency of clinical research activities. The unpredictable nature of these events poses a substantial restraint, hindering progress and complicating the management of clinical trial supplies on a global scale.

Market Trends of the Clinical Trial Supplies Market

The Clinical Trial Supplies market is experiencing a significant shift towards decentralized clinical trials, driven by technological advancements and the growing acceptance of virtual study methodologies. This trend is enabling remote patient monitoring and broadening participant access, resulting in reduced operational costs and expedited trial timelines. By facilitating greater inclusivity and efficiency, decentralized trials are transforming traditional clinical research models, allowing for more dynamic patient engagement and data collection. As a result, pharmaceutical companies and CROs are increasingly investing in innovative supply chain solutions to adapt to these changes, positioning the market for continued growth and evolution through enhanced logistics and tailored supply strategies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis

Global Clinical Trial Supplies Market Size by Phase & CAGR (2025-2032)

• Market Overview
• Phase I
• Phase II
• Phase III
• Others

Global Clinical Trial Supplies Market Size by Products and Services & CAGR (2025-2032)

• Market Overview
• Manufacturing
• Storage and Distribution
• Supply Chain Management

Global Clinical Trial Supplies Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Pharmaceutical
• Biologics
• Medical device
• Others

Global Clinical Trial Supplies Market Size by Therapeutic & CAGR (2025-2032)

• Market Overview
• Oncology
• CNS
• Cardiovascular
• Infectious disease
• Metabolic disorders
• Others

Global Clinical Trial Supplies Market Size & CAGR (2025-2032)

• North America (Phase, Products and Services, End Use, Therapeutic)
  • US
  • Canada
• Europe (Phase, Products and Services, End Use, Therapeutic)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Phase, Products and Services, End Use, Therapeutic)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Phase, Products and Services, End Use, Therapeutic)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Phase, Products and Services, End Use, Therapeutic)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Almac Group (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marken (UPS) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PCI Pharma Services (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sharp Services LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cencora, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myonex (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinigen Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inceptua Group (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQVIA (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Catalent, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Pharma Solutions (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocair (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• World Courier (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Klifo A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DHL Supply Chain (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations